Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score

Author:

Tseng Luke1,Hittesdorf Erin2,Berman Mitchell F.2,Jordan Desmond A.2,Yoh Nina3,Elisman Katerina2,Eiseman Katherine A.1,Miao Yuqi4,Wang Shuang4,Wagener Gebhard2ORCID

Affiliation:

1. Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA

2. Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA

3. Department of Neurological Surgery, Columbia University Medical Center, New York, NY, USA

4. Department of Biostatistics, Mailman School of Public Health, New York, NY, USA

Abstract

Background. COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to deteriorate. Methods. This is a retrospective cohort study of all COVID-19 patients admitted to a tertiary academic medical center in New York City during the COVID-19 crisis in spring 2020. The primary combined endpoint included intubation, stage 3 acute kidney injury (AKI), or death. Laboratory tests available on admission in at least 70% of patients (and age) were included for univariate analysis. Tests that were statistically or clinically significant were then included in a multivariate binary logistic regression model using stepwise exclusion. 70% of all patients were used to train the model, and 30% were used as an internal validation cohort. The aim of this study was to develop and validate a model for COVID-19 severity based on biomarkers. Results. Out of 2545 patients, 833 (32.7%) experienced the primary endpoint. 53 laboratory tests were analyzed, and of these, 47 tests (and age) were significantly different between patients with and without the endpoint. The final multivariate model included age, albumin, creatinine, C-reactive protein, and lactate dehydrogenase. The area under the ROC curve was 0.850 (CI [95%]: 0.813, 0.889), with a sensitivity of 0.800 and specificity of 0.761. The probability of experiencing the primary endpoint can be calculated as p = e 2.4475 + 0.02492 age 0.6503 albumin + 0.81926 creat + 0.00388 CRP + 0.00143 LDH / 1 + e 2.4475 + 0.02492 age 0.6503 albumin + 0.81926 creat + 0.00388 CRP + 0.00143 LDH . Conclusions. Our study demonstrated that poor outcome in COVID-19 patients can be predicted with good sensitivity and specificity using a few laboratory tests. This is useful for identifying patients at risk during admission.

Publisher

Hindawi Limited

Subject

Critical Care and Intensive Care Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3